298 related articles for article (PubMed ID: 23370371)
1. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.
Touma Z; Gladman DD; Urowitz MB
Curr Opin Rheumatol; 2013 Mar; 25(2):164-70. PubMed ID: 23370371
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.
Saad CG; Borba EF; Aikawa NE; Silva CA; Pereira RM; Calich AL; Moraes JC; Ribeiro AC; Viana VS; Pasoto SG; Carvalho JF; França IL; Guedes LK; Shinjo SK; Sampaio-Barros PD; Caleiro MT; Goncalves CR; Fuller R; Levy-Neto M; Timenetsky Mdo C; Precioso AR; Bonfa E
Ann Rheum Dis; 2011 Jun; 70(6):1068-73. PubMed ID: 21540203
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
[TBL] [Abstract][Full Text] [Related]
5. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
[TBL] [Abstract][Full Text] [Related]
6. [Flu vaccine and auto-immune and/or inflammatory diseases].
Duchet-Niedziolka P; Hanslik T; Mouthon L; Guillevin L; Launay O
Presse Med; 2011 Mar; 40(3):248-52. PubMed ID: 21232908
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
Urowitz MB; Anton A; Ibanez D; Gladman DD
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
[TBL] [Abstract][Full Text] [Related]
8. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.
Muller RB; Maier R; Hoschler K; Zambon M; Ludewig B; Herrmann M; Schulze-Koops H; von Kempis J
Clin Exp Rheumatol; 2013; 31(5):723-30. PubMed ID: 23806224
[TBL] [Abstract][Full Text] [Related]
9. Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases.
Sengler C; Niewerth M; Kallinich T; Nimtz-Talaska A; Haller M; Huppertz HI; Minden K
Clin Rheumatol; 2014 Jan; 33(1):137-9. PubMed ID: 24288046
[TBL] [Abstract][Full Text] [Related]
10. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
[TBL] [Abstract][Full Text] [Related]
11. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
Meyer S; Adam M; Schweiger B; Ilchmann C; Eulenburg C; Sattinger E; Runte H; Schlüter M; Deuse T; Reichenspurner H; Costard-Jäckle A
Transplantation; 2011 May; 91(9):1031-5. PubMed ID: 21358365
[TBL] [Abstract][Full Text] [Related]
12. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
13. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
14. Can influenza H1N1 vaccination lead to the membranous glomerulonephritis?
Kutlucan A; Gonen I; Yildizhan E; Aydin Y; Sav T; Yildirim U
Indian J Pathol Microbiol; 2012; 55(2):239-41. PubMed ID: 22771654
[TBL] [Abstract][Full Text] [Related]
15. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
[TBL] [Abstract][Full Text] [Related]
16. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
Ribeiro AC; Guedes LK; Moraes JC; Saad CG; Aikawa NE; Calich AL; França IL; Carvalho JF; Sampaio-Barros PD; Goncalves CR; Borba EF; Timenetsky Mdo C; Precioso AR; Duarte A; Bonfa E; Laurindo IM
Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.
Fukase H; Furuie H; Yasuda Y; Komatsu R; Matsushita K; Minami T; Suehiro Y; Yotsuyanagi H; Kusadokoro H; Sawata H; Nakura N; Lattanzi M
Vaccine; 2012 Jul; 30(33):5030-7. PubMed ID: 22472791
[TBL] [Abstract][Full Text] [Related]
18. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N
Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of children and adolescents with rheumatic diseases.
Dell' Era L; Esposito S; Corona F; Principi N
Rheumatology (Oxford); 2011 Aug; 50(8):1358-65. PubMed ID: 21482543
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.
Elkayam O; Amir S; Mendelson E; Schwaber M; Grotto I; Wollman J; Arad U; Brill A; Paran D; Levartovsky D; Wigler I; Caspi D; Mandelboim M
Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1062-7. PubMed ID: 21425247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
